Bergapten
CAS No. 484-20-8
Bergapten ( —— )
Catalog No. M14621 CAS No. 484-20-8
5-Methoxypsoralen, a naturally occurring linear furocoumarin, has been successfully used in combination with ultraviolet (UV) A irradiation [psoralen plus UV (PUVA)] to manage psoriasis and vitiligo.
Purity : >98%(HPLC)
Size | Price / USD | Stock | Quantity |
500MG | 61 | In Stock |
|
1G | 105 | In Stock |
|
Biological Information
-
Product NameBergapten
-
NoteResearch use only, not for human use.
-
Brief Description5-Methoxypsoralen, a naturally occurring linear furocoumarin, has been successfully used in combination with ultraviolet (UV) A irradiation [psoralen plus UV (PUVA)] to manage psoriasis and vitiligo.
-
Description5-Methoxypsoralen, a naturally occurring linear furocoumarin, has been successfully used in combination with ultraviolet (UV) A irradiation [psoralen plus UV (PUVA)] to manage psoriasis and vitiligo; inhibit proliferation in the human hepatocellular carcinoma cell line.
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetP450
-
RecptorCYP
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number484-20-8
-
Formula Weight216.19
-
Molecular FormulaC12H8O4
-
Purity>98%(HPLC)
-
SolubilityDMSO: 5 mg/mL (23.12 mM)
-
SMILESCOC1=C2C=CC(=O)OC2=CC2=C1C=CO2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Rhodionin
Rhodionin and rhodionin can inhibit cytochrome P450 2D6 non-competitively with high specificity which could have implications for interactions with co-administered drugs; they can significantly suppress the elevation of the postprandial blood triglyceride level suggests that they may be to the treatment of lifestyle-related diseases such as hyperlipidemia and exogeneous obesity and to health foods.
-
(-)-Sparteine sulfat...
Sparteine is a class 1a antiarrhythmic agent; a sodium channel blocker. It is an alkaloid and can be extracted from scotch broom.
-
Praeruptorin A
Praeruptorin A could exhibit its anti-osteoclastogenic activity by inhibiting p38/Akt-c-Fos-NFATc1 signaling and PLCγ-independent Ca(2+) oscillation.